Opportunity Information: Apply for RFA CA 19 041

Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) is a National Institutes of Health opportunity (through the National Cancer Institute as part of the Informatics Technology for Cancer Research, or ITCR, program) that funds the ongoing operation and upkeep of proven, widely used informatics tools and resources for cancer research. Rather than paying to invent brand-new software or push an early prototype into a mature product, this announcement is aimed at keeping high-value resources reliable, accessible, and easy to use for the research community that already depends on them. The award mechanism is a Cooperative Agreement (U24), meaning recipients should expect substantial NIH/NCI involvement and collaboration during the project period, with the work carried out in partnership with program staff to meet shared goals.

The core purpose is to strengthen informatics resources that improve how cancer-related data and knowledge are acquired, managed, analyzed, and shared across the entire cancer research continuum. That includes areas such as basic cancer biology, treatment and diagnosis, early detection, risk assessment and prevention, cancer control and epidemiology, and work focused on cancer health disparities. In practical terms, the FOA is about sustaining the kinds of tools, platforms, services, and data/knowledge resources that enable researchers to handle complex datasets, integrate information from multiple sources, apply computational methods, and disseminate results in ways that accelerate discovery and improve outcomes.

A key expectation is a clear sustainment plan that explains why the resource deserves continued support and demonstrates the impact it has already had. Applications are expected to justify the value of the resource to the field, show evidence of adoption and usefulness, and explain how continued operations will keep delivering benefits to cancer researchers. This typically implies describing concrete metrics and evidence (for example, user base, usage levels, scientific outputs enabled, citations, integrations into workflows, community reliance, or other indicators of real-world utility), along with what will be improved during the sustainment period.

The announcement also emphasizes user experience and availability. Applicants are expected not only to keep the resource running, but to improve how people interact with it and how easily they can access and depend on it. That can include efforts like strengthening documentation and training materials, improving interfaces and workflows, enhancing performance and reliability, ensuring interoperability, supporting cloud or scalable deployment where appropriate, tightening security and privacy protections when relevant, and maintaining responsive user support. The overall idea is to reduce friction for researchers and increase the practical, day-to-day value of the tool or resource.

Another central theme is active engagement with the research community the resource serves. The FOA calls for mechanisms to assess and maximize value to users and to support collaboration and deep engagement between the resource team and the targeted community. That means applicants should describe how they will gather feedback, prioritize enhancements, track satisfaction and outcomes, build partnerships, and ensure the resource continues to align with evolving scientific needs. The expectation is not passive maintenance, but a managed, community-facing sustainment effort that keeps the resource relevant and impactful.

Eligibility is broad and includes many types of U.S. organizations and some non-U.S. entities. Eligible applicants include state, county, and local governments; special districts; independent school districts; public and private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities; nonprofits with and without 501(c)(3) status (outside of higher education); for-profit organizations other than small businesses; small businesses; and additional categories noted in the announcement. The FOA explicitly mentions eligibility for organizations such as Historically Black Colleges and Universities, Hispanic-serving institutions, Tribal Colleges and Universities, Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions, as well as non-domestic (foreign) organizations.

From the listing details provided, the opportunity is categorized as discretionary funding, uses the Cooperative Agreement instrument, falls under education/health activity categories, and is associated with CFDA 93.396. The funding opportunity number is RFA-CA-19-041, with an original closing date of 2019-11-20 and a creation date of 2019-03-28. The FOA is described as "clinical trial optional," indicating that a clinical trial component is not required for all projects, but may be allowed if it fits the proposed work and NIH definitions and policies.

Overall, this announcement is designed for teams that already operate a cancer informatics tool or resource with demonstrated community uptake and scientific value, and that can present a credible plan to keep it healthy and evolving. The strongest proposals are positioned to show real-world adoption, a thoughtful operational and improvement roadmap, and a clear strategy for measuring impact while staying tightly connected to the needs of the cancer research community.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.396.
  • This funding opportunity was created on 2019-03-28.
  • Applicants must submit their applications by 2019-11-20. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA CA 19 041

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is the “Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)” opportunity?

This is a National Institutes of Health (NIH) funding opportunity offered through the National Cancer Institute (NCI) under the Informatics Technology for Cancer Research (ITCR) program. It supports the ongoing operation, upkeep, and improvement of proven informatics tools and resources that are already widely used in cancer research and management.

What is the main goal of this funding announcement?

The goal is to keep high-value cancer informatics resources reliable, accessible, and easy to use for the research community that already depends on them. The focus is on sustainment and continuous improvement rather than on creating brand-new software or maturing early prototypes.

What types of projects are a good fit for this FOA?

Projects that maintain and strengthen established informatics tools, platforms, services, and data/knowledge resources used in cancer research. A strong fit is a resource with demonstrated adoption and clear value to researchers, paired with a credible plan to sustain operations and enhance usability, reliability, and community impact.

Is this funding meant to develop new software from scratch?

No. This announcement is not aimed at inventing brand-new software or pushing an early prototype into a mature product. It is intended to sustain and improve resources that are already proven and widely used.

What award mechanism is used for this opportunity?

The award mechanism is a Cooperative Agreement (U24).

What does a Cooperative Agreement (U24) imply about NIH/NCI involvement?

A U24 Cooperative Agreement typically involves substantial NIH/NCI involvement during the project period. Recipients should expect collaboration and partnership with program staff to meet shared goals, rather than operating entirely independently.

What cancer research areas can be supported by sustained informatics resources under this FOA?

The FOA emphasizes resources that improve how cancer-related data and knowledge are acquired, managed, analyzed, and shared across the cancer research continuum. Examples include basic cancer biology, treatment and diagnosis, early detection, risk assessment and prevention, cancer control and epidemiology, and work focused on cancer health disparities.

What kinds of informatics resources are relevant to this announcement?

Relevant resources include tools, platforms, services, and data/knowledge resources that help researchers handle complex datasets, integrate information from multiple sources, apply computational methods, and disseminate results in ways that accelerate discovery and improve outcomes.

What is a “sustainment plan,” and why is it important?

A sustainment plan is a clear explanation of why the resource warrants continued support, what impact it has already had, and how it will continue delivering benefits during the proposed period. This FOA places strong emphasis on demonstrating value and laying out a realistic approach to ongoing operations and improvement.

What evidence of impact or adoption is expected in an application?

Applications are expected to justify the resource’s value to the field and show evidence that it is adopted and useful. Examples of evidence mentioned include user base and usage levels, scientific outputs enabled, citations, integrations into workflows, community reliance, and other indicators of real-world utility.

Does the FOA require applicants to improve the resource, or is basic maintenance enough?

The FOA emphasizes more than passive maintenance. Applicants are expected to keep the resource running while also improving user experience, availability, and day-to-day practical value for researchers.

What kinds of improvements are encouraged under this sustainment-focused FOA?

Examples include strengthening documentation and training materials, improving interfaces and workflows, enhancing performance and reliability, ensuring interoperability, supporting cloud or scalable deployment where appropriate, tightening security and privacy protections when relevant, and maintaining responsive user support.

How important is user experience and accessibility in this opportunity?

User experience and availability are key themes. The FOA stresses reducing friction for researchers and ensuring the resource remains dependable, accessible, and easy to use.

What does the FOA say about engaging with the research community?

The FOA calls for active, ongoing engagement with the resource’s user community. Applicants should describe mechanisms to assess and maximize value to users, gather feedback, prioritize enhancements, track satisfaction and outcomes, build partnerships, and keep the resource aligned with evolving scientific needs.

Is community engagement expected to be ongoing during the project?

Yes. The expectation is a managed, community-facing sustainment effort that keeps the resource relevant and impactful over time, not one-time outreach.

Who is eligible to apply?

Eligibility is broad and includes many types of U.S. organizations and some non-U.S. entities. Eligible applicants include state, county, and local governments; special districts; independent school districts; public and private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities; nonprofits with and without 501(c)(3) status (outside of higher education); for-profit organizations other than small businesses; small businesses; and additional categories noted in the announcement.

Are minority-serving institutions and community-based organizations included in the eligible categories?

Yes. The FOA explicitly mentions eligibility for organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribal Colleges and Universities, Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions.

Are non-U.S. (foreign) organizations eligible to apply?

Yes. The listing explicitly states that non-domestic (foreign) organizations are eligible.

Is a clinical trial required for this funding opportunity?

No. The FOA is described as “clinical trial optional,” meaning a clinical trial component is not required for all projects, but may be allowed if it fits the proposed work and aligns with NIH definitions and policies.

What is the funding opportunity number for this announcement?

The funding opportunity number is RFA-CA-19-041.

What is the CFDA number associated with this opportunity?

The opportunity is associated with CFDA 93.396.

How is this opportunity categorized in the listing details?

It is categorized as discretionary funding, uses the Cooperative Agreement instrument, and falls under education/health activity categories.

What are the key dates provided in the listing details?

The creation date is 2019-03-28, and the original closing date is 2019-11-20.

What kinds of applicants are most competitive based on the description?

Teams that already operate a cancer informatics tool or resource with demonstrated community uptake and scientific value, and that can present a credible plan for ongoing operations, targeted improvements, measurable impact, and strong alignment with the evolving needs of the cancer research community.

What should an application emphasize to align with the FOA’s expectations?

Based on the description, an application should emphasize: (1) demonstrated adoption and value, (2) a clear sustainment plan with concrete metrics, (3) improvements to usability, reliability, and availability, (4) user support, documentation, and training, and (5) active, structured engagement with the research community to guide priorities and measure outcomes.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Advancing Biomarker Discovery and Novel Point-of-Care Diagnostics for Active TB Disease Detection in HIV-1 Infected and Exposed Children (R01 Clinical Trial Optional)

Previous opportunity: Limited Competition: Extramural Research Facilities Restoration Program: Hurricanes Harvey, Irma, and Maria Disaster Relief (C06 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 19 041

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 19 041) also looked into and applied for these:

Funding Opportunity
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Apply for RFA CA 19 040

Funding Number: RFA CA 19 040
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $600,000
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: CNS Data Generation (UM1 Clinical Trial Not Allowed) Apply for RFA DA 19 037

Funding Number: RFA DA 19 037
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed) Apply for RFA DA 19 038

Funding Number: RFA DA 19 038
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed) Apply for RFA DA 19 039

Funding Number: RFA DA 19 039
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 19 047

Funding Number: RFA CA 19 047
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Apply for PAR 19 242

Funding Number: PAR 19 242
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Abuse and Addiction Scientists (R25 - Clinical Trials Not Allowed) Apply for PAR 19 246

Funding Number: PAR 19 246
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
Limited Competition: Modular Budget Research Project Grant for NIH Nurse Scientist Scholars (R01 Clinical Trial Optional) Apply for PAR 19 256

Funding Number: PAR 19 256
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) Apply for PAR 19 258

Funding Number: PAR 19 258
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) Apply for PAR 19 259

Funding Number: PAR 19 259
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $10,000,000
Limited Competition Cohort Studies of HIV/AIDS and Substance Abuse (U01 Clinical Trial Not Allowed) Apply for RFA DA 20 005

Funding Number: RFA DA 20 005
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional) Apply for PAR 19 264

Funding Number: PAR 19 264
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HLA and KIR Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed) Apply for RFA AI 19 041

Funding Number: RFA AI 19 041
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional) Apply for PAR 19 277

Funding Number: PAR 19 277
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Blockchain Technology to Improve SUD Care (R43/R44 - Clinical Trial Optional) Apply for RFA DA 20 012

Funding Number: RFA DA 20 012
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Blockchain Technology to Improve SUD Care (R41/R42 - Clinical Trial Optional) Apply for RFA DA 20 011

Funding Number: RFA DA 20 011
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) Apply for PAR 19 278

Funding Number: PAR 19 278
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional) Apply for PAR 19 279

Funding Number: PAR 19 279
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Digital Health Technologies to Address the Social Determinants of Health in context of Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) Apply for RFA DA 20 017

Funding Number: RFA DA 20 017
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional) Apply for PAR 19 280

Funding Number: PAR 19 280
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 19 041", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: